InvestorsHub Logo
Followers 30
Posts 2401
Boards Moderated 0
Alias Born 05/20/2008

Re: ProfitScout post# 109655

Thursday, 01/24/2019 2:18:56 PM

Thursday, January 24, 2019 2:18:56 PM

Post# of 194878
Agreed... Looking very good for RXMD...

The RXMD high growth story for 2019 is getting better and better. Revenue returns should also multiply dramatically through the acquisition program that management is bringing to the picture here.

Jimmy's list of RXMD accomplishments bears repeating:


- Gone from $.005 to current $.07 to as high as $.2659

- Revenues grown from $9 million annual net revenues to over $21 not counting the upcoming acquisition of over $18 million annual net revenues.

- Gone from 100,000 prescriptions to over 300,000 prescriptions annually.

- Developed Tele-Pharmacy Platform

- Uplisted to OTCQB and Penny Stock Exempt

- Soon to be 3 Years of Consecutive Audited Financial Statements

- Garnering some great market share from physicians and hospitals that see PharmcoRx as the preferred pharmacy if you ask me.

- Continually Expand both Organically and with Acquisitions.

- DischargeRx Partnership with WestChester Hospital

- 14 out of state licenses in which about 10% of revenue comes from.

- 4 340B contracts that have increased 340B Gross Revenues alone to over $6 million from $2.75 million in 2017
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RXMD News